91 related articles for article (PubMed ID: 30341867)
1. The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients.
Ankit BS; Agrawal R; Gadhwal A; Chahar C; Agrawal RP
J Assoc Physicians India; 2018 Mar; 66(3):38-41. PubMed ID: 30341867
[TBL] [Abstract][Full Text] [Related]
2. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128
[TBL] [Abstract][Full Text] [Related]
3. [Effects of metformin therapy on serum CA125 levels and its related factors in type 2 diabetics].
Hou W; Zhang D; Lu W; Yin J; Li M; Lu F; Liu F; Jia W
Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1380-3. PubMed ID: 25142987
[TBL] [Abstract][Full Text] [Related]
4. Metformin reduces serum CA199 levels in type 2 diabetes Chinese patients with time-effect and gender difference.
Zhang D; Hou W; Liu F; Yin J; Lu W; Li M; Zheng T; Lu F; Bao Y; Jia W
Diabetes Technol Ther; 2015 Feb; 17(2):72-9. PubMed ID: 25548963
[TBL] [Abstract][Full Text] [Related]
5. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
7. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.
Wulffelé MG; Kooy A; de Zeeuw D; Stehouwer CD; Gansevoort RT
J Intern Med; 2004 Jul; 256(1):1-14. PubMed ID: 15189360
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
Schernthaner G; Matthews DR; Charbonnel B; Hanefeld M; Brunetti P;
J Clin Endocrinol Metab; 2004 Dec; 89(12):6068-76. PubMed ID: 15579760
[TBL] [Abstract][Full Text] [Related]
10. Influence of therapy with metformin on the concentration of certain divalent cations in patients with non-insulin-dependent diabetes mellitus.
Doşa MD; Hangan LT; Crauciuc E; Galeş C; Nechifor M
Biol Trace Elem Res; 2011 Jul; 142(1):36-46. PubMed ID: 20567934
[TBL] [Abstract][Full Text] [Related]
11. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
[TBL] [Abstract][Full Text] [Related]
12. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
[TBL] [Abstract][Full Text] [Related]
13. Fasting plasma lactate concentrations in ambulatory elderly patients with type 2 diabetes receiving metformin therapy: a retrospective cross-sectional study.
Lin YC; Lin LY; Wang HF; Lin HD
J Chin Med Assoc; 2010 Dec; 73(12):617-22. PubMed ID: 21145508
[TBL] [Abstract][Full Text] [Related]
14. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
15. Metformin monotherapy for type 2 diabetes mellitus.
Saenz A; Fernandez-Esteban I; Mataix A; Ausejo M; Roque M; Moher D
Cochrane Database Syst Rev; 2005 Jul; (3):CD002966. PubMed ID: 16034881
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes.
Xu T; Brandmaier S; Messias AC; Herder C; Draisma HH; Demirkan A; Yu Z; Ried JS; Haller T; Heier M; Campillos M; Fobo G; Stark R; Holzapfel C; Adam J; Chi S; Rotter M; Panni T; Quante AS; He Y; Prehn C; Roemisch-Margl W; Kastenmüller G; Willemsen G; Pool R; Kasa K; van Dijk KW; Hankemeier T; Meisinger C; Thorand B; Ruepp A; Hrabé de Angelis M; Li Y; Wichmann HE; Stratmann B; Strauch K; Metspalu A; Gieger C; Suhre K; Adamski J; Illig T; Rathmann W; Roden M; Peters A; van Duijn CM; Boomsma DI; Meitinger T; Wang-Sattler R
Diabetes Care; 2015 Oct; 38(10):1858-67. PubMed ID: 26251408
[TBL] [Abstract][Full Text] [Related]
17. Association of trace metal elements with lipid profiles in type 2 diabetes mellitus patients: a cross sectional study.
Wolide AD; Zawdie B; Alemayehu T; Tadesse S
BMC Endocr Disord; 2017 Oct; 17(1):64. PubMed ID: 29029608
[TBL] [Abstract][Full Text] [Related]
18. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
Kendall DM; Rubin CJ; Mohideen P; Ledeine JM; Belder R; Gross J; Norwood P; O'Mahony M; Sall K; Sloan G; Roberts A; Fiedorek FT; DeFronzo RA
Diabetes Care; 2006 May; 29(5):1016-23. PubMed ID: 16644631
[TBL] [Abstract][Full Text] [Related]
19. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
20. [Primary preventive effect of metformin upon atherosclerosis in patients with type 2 diabetes mellitus].
Zhang XY; Du JL; Jia YJ; Bai R; Yang Y; Ba Y; Xing Q; Men LL
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2134-7. PubMed ID: 20058619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
